AD
Immunology
Prevalence
61.0 / 100K
Incidence
18.0 / 100K/yr
2564 drugs in development·549 companies·1 clinical trial
Drug Pipeline by Phase
Approved(594)
Phase 3(454)
Phase 2(564)
Phase 1(519)
Preclinical(91)
Unknown(68)
BLA Filed(2)
N/A(9)
Phase 1/Phase 2(135)
Phase 2/Phase 3(26)
Phase 4(102)
Compare drugs
Frequently asked questions
How many drugs are in development for AD?
BioSniper tracks 2564 drugs in development for AD across 549 companies.
How many clinical trials target AD?
There are 1 clinical trial targeting AD tracked by BioSniper.
What is the prevalence of AD?
The estimated prevalence of AD is approximately 61.0 per 100,000 population.
Deep-dive into AD
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis